<?xml version="1.0" encoding="UTF-8"?>
<ref id="B9-molecules-25-02944">
 <label>9.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Khan</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Jha</surname>
    <given-names>R.K.</given-names>
   </name>
   <name>
    <surname>Amera</surname>
    <given-names>G.M.</given-names>
   </name>
   <name>
    <surname>Jain</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Singh</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Pathak</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Singh</surname>
    <given-names>R.P.</given-names>
   </name>
   <name>
    <surname>Muthukumaran</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Singh</surname>
    <given-names>A.K.</given-names>
   </name>
  </person-group>
  <article-title>Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2â€²-O-ribose methyltransferase</article-title>
  <source>J. Biomol. Struct. Dyn.</source>
  <year>2020</year>
  <fpage>1</fpage>
  <lpage>14</lpage>
  <pub-id pub-id-type="doi">10.1080/07391102.2020.1753577</pub-id>
 </element-citation>
</ref>
